BX
$110.43-3.04 (-2.68%)
Blackstone Inc.
Recent News
Blackstone Weighs Nucleus Network Sale And Potential Portfolio Reallocation
Blackstone is exploring a sale of its clinical trials business Nucleus Network, with major private equity firms expected to participate in the process. The potential auction could also attract interest from global contract research organizations looking to expand their clinical research capabilities. For investors watching NYSE:BX, this move sits against a mixed share price backdrop. Blackstone closed at $110.43, with a 3.4% gain over the past week, alongside declines of 16.9% over 30 days,...
Are liquidity risks testing the stability of private credit?
S&P Global Ratings global head of private markets analytics, Ruth Yang, joins Julie Hyman to break down the rising pressure in private credit markets amid liquidity concerns as more investors withdraw from these funds.
Investors Are Fleeing Private Credit. What the Funds Should Do Now.
Private credit was initially an investment mainly for institutions. Then the industry made a big bet on retail investors.
Sector Update: Financial Stocks Lean Lower Premarket Friday
Financial stocks were leaning lower premarket Friday, with the State Street Financial Select Sector
BitFuFu Inc. (FUFU) Reports Q4 Loss, Misses Revenue Estimates
BitFuFu Inc. (FUFU) delivered earnings and revenue surprises of -1,233.33% and -3.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?